medical_theme
Neuralink & BCI Commercialization
♥ 778 Thanks from members
The web sentiment around Neuralink and BCI commercialization highlights rapid clinical and valuation momentum, driven by FDA breakthrough designations, rising private valuations approaching $40 billion, and prominent institutional investments like OpenAI-backed Merge Labs, tempered by pre-revenue status, complex regulatory hurdles, and stringent ethical concerns.